Introduction
Many U.S. service members returning from the wars involving Iraq and Afghanistan since
1990–1991 have returned with chronic multi-symptom illnesses [1] (often disabling) for which the pathophysiology or etiology is unknown. Recent research includes the finding that some multi-symptom illnesses such as Gulf War illness (GWI) and myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) are associated with pre-lytic herpes virus partial reactivation [2–5].
This partial reactivation involves the synthesis of herpetic virus dUTPase protein antigens with
resulting stimulation of inflammatory intermediates. There has been independent documentation of increased inflammatory cytokines in veterans with GWI [6–8]. There have also been clinical studies which suggest an atypical or partial reactivation of herpetic viruses as an etiology of chronic multi-symptom illnesses including ME/CFS and in those with neuropathic chronic pain syndromes.
Non routine, experimental, antiviral therapy has been used with moderate success to treat patients with these chronic multi-symptom illnesses [9–12].
The active form of vitamin D, 1,25(OH)2 D3 is a hormone that can be produced outside the
kidneys in immune system cells, and this hormone uses vitamin D receptors on activated lymphocytes,macrophages, and dendritic cells [13–16]. Persistent low serum levels of active vitamin D precursor, 25(OH)D3 may chronically impair the immune system in individuals with multi-symptom illnesses...